Mason Chilmonczyk

CEO & Co-founder @ Andson Biotech (YC W22)

Co-founder

Andson Biotech· Winter 2022🇺🇸 Atlanta, Georgia, United States

in LinkedIn

20232023 Finalist· BioTools Innovator

Founder · since 2022

Company

BioTools Innovator

Role

2023 Finalist

Stage

—

no public source

Raised

—

no public source

Based

—

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

Andson Biotech

Empowering Mass Spec for Biotech and Beyond

Winter 2022

Experience

Career

Andson Biotech
Co-founder
Chief Executive Officer & Co-founder · Atlanta, Georgia, United States · 2022 – Present
2022
BioTools Innovator
2023 Finalist · 2023
2023
Merck Digital Sciences Studio
Inaugural Cohort Member · 2022 – 2023
2022
Y Combinator
Winter 2022 Batch · 2022
2022
Georgia Institute of Technology
Postdoctoral Researcher · Atlanta, Georgia, United States · 2020 – 2022
2020
Georgia Institute of Technology
Graduate Research Assistant · Atlanta, Georgia, United States · 2014 – 2020
2014
Pharmaworks
Mechanical Engineering Intern · 2013 – 2014
2013
University of South Florida
Undergraduate Research Assistant · 2012 – 2014
2012
QTM
Manufacturing Assistant · 2011 – 2013
2011

Bio

Mason is the co-founder and CEO of Andson Biotech, an academic spinout based on Mason's research at the Georgia Institute of Technology. At Andson, Mason is driving the company's mission to develop novel methodologies for advanced biomanufacturing discovery and monitoring. Mason is formally trained as a mechanical engineer with a BS from the University of South Florida ('14) and an MS and PhD from Georgia Tech ('17, '20).